Skip to main content
PepStack

Melanotan II

Sexual Health
MT-2MT-IIMelanotan 2

Overview

Melanotan II (MT-2, MT-II, Melanotan 2) is a synthetic analogue of the naturally occurring peptide hormone alpha-melanocyte-stimulating hormone (α-MSH). It was originally developed in the 1980s at the University of Arizona as a potential treatment for skin conditions by stimulating melanin production. The compound is a cyclic heptapeptide with a structure designed to mimic the effects of α-MSH, enhancing its stability and activity. Researchers have synthesized Melanotan II through solid-phase peptide synthesis, a method that allows for precise control over the peptide sequence and structure. Research on Melanotan II has primarily focused on its effects on skin pigmentation, sexual function, and appetite regulation. Researchers have observed that Melanotan II can induce skin tanning without exposure to UV radiation, making it a subject of interest for reducing skin cancer risk. Additionally, it has been investigated for its potential to enhance libido and erectile function, as well as its effects on appetite suppression. The mechanism of action of Melanotan II involves binding to melanocortin receptors, particularly MC1R and MC4R. These receptors are part of the G protein-coupled receptor family and play roles in skin pigmentation, energy homeostasis, and sexual function. By activating these receptors, Melanotan II can influence various physiological processes, including melanin production and sexual arousal. Pharmacokinetic studies of Melanotan II indicate that it has a half-life of approximately 1-2 hours when administered subcutaneously. The compound is relatively stable, but its bioavailability varies depending on the route of administration, with subcutaneous injection being the most effective. Current research on Melanotan II is limited, and it is not approved by regulatory agencies for therapeutic use. In the United States, the FDA has not approved Melanotan II as a drug, and it is often sold as a research chemical. Its regulatory status varies by country, and it remains a compound of interest for further investigation into its potential therapeutic applications.

Mechanism of Action

Melanotan II exerts its effects primarily through activation of melanocortin receptors, particularly MC1R and MC4R. These receptors are involved in pathways regulating skin pigmentation, energy balance, and sexual function, allowing Melanotan II to influence melanin production and sexual arousal.

Molecular Data

FormulaC50H69N15O9
Molecular Weight1024.2 g/mol
CAS Number121062-08-6
PubChem CID92432

Half-Life

Subcutaneous~1-2 hours
IntranasalNot applicable
OralPoor bioavailability

Subcutaneous administration is the most studied route, with limited data on other routes.

Storage

Lyophilized

Stable for 2+ years at -20°C, 12 months at 4°C

Reconstituted

Use within 14 days when refrigerated at 4°C

Avoid

Avoid repeated freeze-thaw cycles, direct light

Solvent

Bacteriostatic water or sterile saline recommended

Solubility

Melanotan II is soluble in water and DMSO.

Legal Status

🇩🇪DE

Not approved as a medicinal product. Not a controlled substance. Sale as research chemical is a legal grey area.

🇺🇸US

Not approved by the FDA as a drug. Not scheduled by the DEA.

🇦🇺AU

Not approved by the TGA. Considered a prescription-only medication.

🇬🇧UK

Not approved by the MHRA. Sale and distribution are restricted.

Legal status information is provided for general reference only and may not reflect the most current regulatory changes. Always verify with official government sources before making any decisions.

10 Research Publications

5-Hydroxypyrroloindoline Affords Tryptathionine and 2,2'-bis-Indole Peptide Staples: Application to Melanotan-II.

Unknown

Chemistry (Weinheim an der Bergstrasse, Germany) · 2024

Researchers studied new ways to create unique peptide structures using natural compounds. They discovered efficient methods to combine specific chemical components to form two types of peptide staples, which could enhance the effectiveness of peptide-based drugs. This research lays the groundwork for further exploration of these novel peptide structures in drug development.

  • Researchers found an efficient method to create tryptathionine and 2,2'-bis-indole staples from a compound called 5-hydroxypyrroloindoline.
  • The study demonstrated the use of protective groups to achieve selective chemical reactions in peptide synthesis.
  • Both types of stapled peptides showed strong binding properties, indicating potential for use in drug development.
PubMed

Melatonin Induces Analgesic Effects through MT

Human

Research (Washington, D.C.) · 2024

Researchers studied the effects of melatonin, a hormone known for regulating sleep, on neuropathic pain in mice. They found that melatonin significantly reduced pain symptoms in a dose-dependent manner, suggesting it may have potential as a pain relief option through specific receptors in the brain.

  • Researchers observed that melatonin administration led to a significant reduction in neuropathic pain symptoms in mice.
  • The pain relief effects of melatonin were found to be dose-dependent.
  • The study indicated that the analgesic effects of melatonin are mediated by specific receptors in the brain.
PubMed

The location, physiology, pathology of hippocampus Melatonin MT

Review

European journal of medicinal chemistry · 2023

Researchers reviewed the role of melatonin, a hormone produced by the pineal gland, in the brain, particularly its effects on the hippocampus, which is crucial for memory and emotions. They found that melatonin is released into the cerebrospinal fluid and absorbed by nearby tissues, influencing brain function.

  • Researchers observed that melatonin is synthesized and released directly into the cerebrospinal fluid of the brain.
  • The hippocampus, important for emotional responses and memory, is located near the area where melatonin is released.
  • The study highlights the potential physiological roles of melatonin in brain function, particularly in relation to the hippocampus.
PubMed

Melanotan-II reverses memory impairment induced by a short-term HF diet.

Unknown

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2023

Researchers found that a short-term high-fat diet negatively affected memory and behavior in zebrafish. They observed that these impairments could be reversed by a compound called Melanotan-II, suggesting a potential link between diet and brain health. This study highlights the significant impact of diet on neurological functions, even over a brief period.

  • Zebrafish on a high-fat diet showed memory impairment and increased anxiety after just three weeks.
  • Melanotan-II reversed the negative effects of the high-fat diet on memory and behavior in zebrafish.
  • This research is the first to demonstrate the impact of a short-term high-fat diet on neurobehavioral conditions.
PubMed

Melatonin receptors, brain functions, and therapies.

Review

Handbook of clinical neurology · 2021

Researchers reviewed how melatonin, a hormone produced by the pineal gland at night, interacts with specific receptors in the brain. They explored its role in various brain functions and potential therapeutic applications. This study highlights the importance of melatonin in regulating sleep and other brain activities.

  • Researchers observed that melatonin binds to two main receptors in the brain, influencing various physiological processes.
  • The review found that melatonin plays a significant role in regulating sleep patterns and circadian rhythms.
  • Researchers noted potential therapeutic uses of melatonin in managing sleep disorders and other brain-related conditions.
PubMed

Melanotan II: a possible cause of renal infarction: review of the literature and case report.

Review

CEN case reports · 2020

Researchers reviewed the effects of Melanotan II, a drug known for increasing skin pigmentation and sexual stimulation, and its potential link to renal infarction, a serious kidney condition. They presented a case where renal infarction was likely caused by Melanotan II, highlighting concerns about its safety and effects on kidney health.

  • Researchers found that renal infarction, a rare and serious condition, can occur due to the use of Melanotan II.
  • The study observed that Melanotan II may lead to kidney injury through thrombotic effects and potential toxicity.
  • Previous reports have indicated that Melanotan II can cause rhabdomyolysis and renal failure, raising safety concerns.
PubMed

Differential Function of Melatonin MT

Review

Frontiers in endocrinology · 2019

Researchers reviewed the role of melatonin receptors in the body, focusing on their involvement in various physiological processes. They found that these receptors play a significant role in regulating sleep, mood, and other bodily functions. The study highlights the complexity of melatonin's effects through its different receptor types.

  • Researchers observed that melatonin receptors are crucial for regulating sleep patterns.
  • The review highlighted the impact of these receptors on mood and emotional well-being.
  • Researchers found that different types of melatonin receptors have distinct physiological roles.
PubMed

A glimpse into the underground market of melanotan.

Human

Dermatology online journal · 2018

This study explored the use of melanotan-I and melanotan-II, substances that mimic a hormone to promote tanning, which are often bought illegally online. Researchers found that users shared their motivations, concerns, and experiences with these unregulated products through an anonymous survey posted on an online forum.

  • Researchers observed that users were motivated by the desire for a tan and the convenience of online purchasing.
  • Participants expressed hesitation due to safety concerns and the lack of regulation surrounding these substances.
  • Many users indicated plans to continue using melanotan despite the potential risks associated with its use.
PubMed

Melatonin Receptor Signaling: Impact of Receptor Oligomerization on Receptor Function.

Review

International review of cell and molecular biology · 2018

Researchers reviewed the role of melatonin receptors, which are important for regulating sleep and other bodily functions. They observed that the way these receptors interact and form complexes, known as oligomerization, can significantly influence their function. This understanding may help in exploring new therapeutic approaches related to sleep and circadian rhythms.

  • Researchers found that the oligomerization of melatonin receptors affects their signaling capabilities.
  • The study observed that different receptor combinations can lead to varied physiological responses.
  • Researchers highlighted the potential implications of receptor interactions for developing new treatments related to sleep disorders.
PubMed

Metallothionein in Brain Disorders.

Review

Oxidative medicine and cellular longevity · 2017

Researchers reviewed the role of metallothioneins, proteins that help manage essential metals in the brain, and their involvement in various brain disorders. They found that certain types of these proteins are linked to neurodegenerative diseases like Alzheimer's and Parkinson's, highlighting their importance in brain health.

  • Researchers observed that metallothioneins are crucial for maintaining metal balance in brain cells.
  • The study found that metallothionein III is associated with the development of neurodegenerative diseases.
  • Evidence suggests that metallothioneins may also play a role in other neurological disorders.
PubMed

Track Melanotan II in PepStack

Log your research cycles, set reminders and visualize serum levels.

This page is for informational and research purposes only. All information is based on published scientific literature. Nothing on this page constitutes medical advice or replaces consultation with a qualified healthcare professional.